Lee Ainslie Takeda Pharmaceutical CO LTD Transaction History

Maverick Capital LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $9.32 Million - $14.5 Million	-716,145 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $814,561 - $1.01 Million	-48,256 Reduced 6.31%	716,145 $14.1 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $14.8 Million - $16.5 Million	-918,487 Reduced 54.58%	764,401 $13.1 Million
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $974,539 - $1.2 Million	-58,778 Reduced 3.37%	1,682,888 $29.8 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $22.7 Million - $29.2 Million	1,356,666 Added 352.38%	1,741,666 $35.5 Million
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $6.02 Million - $8.12 Million	385,000 New	385,000 $6.48 Million

336

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.